Skip to main content
Premium Trial:

Request an Annual Quote

Back to the Ivy

Eli Lilly’s senior VP for discovery and clinical research, William Chin, is heading to Harvard Medical School, reports the Wall Street Journal Health Blog. There, Chin will be the executive dean for research, a new position. According to the medical school dean, Chin will "conceptualize and develop new research initiatives, such as the therapeutics discovery initiative, envisioned as a focused and innovative effort to bring together the enormous expertise of our community in order to find effective new ways for transforming the world’s most vital biomedical research into therapies that can directly improve human health." Prior to joining Lilly, Chin was a professor at Harvard, where he also received his medical degree.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.